These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30090324)

  • 1. Mechanistic understanding of molecular initiating events (MIEs) using NMR spectroscopy.
    Sanderson PN; Simpson W; Cubberley R; Aleksic M; Gutsell S; Russell PJ
    Toxicol Res (Camb); 2016 Jan; 5(1):34-44. PubMed ID: 30090324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining molecular initiating events in the adverse outcome pathway framework for risk assessment.
    Allen TE; Goodman JM; Gutsell S; Russell PJ
    Chem Res Toxicol; 2014 Dec; 27(12):2100-12. PubMed ID: 25354311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A History of the Molecular Initiating Event.
    Allen TE; Goodman JM; Gutsell S; Russell PJ
    Chem Res Toxicol; 2016 Dec; 29(12):2060-2070. PubMed ID: 27989138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Mechanistic Framework for Integrating Chemical Structure and High-Throughput Screening Results to Improve Toxicity Predictions.
    Nelms MD; Mellor CL; Enoch SJ; Judson RS; Patlewicz G; Richard AM; Madden JM; Cronin MTD; Edwards SW
    Comput Toxicol; 2018 Nov; 8():1-12. PubMed ID: 36779220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the adverse outcome pathway (AOP) concept to structure the available in vivo and in vitro mechanistic data for allergic sensitization to food proteins.
    van Bilsen JHM; Sienkiewicz-Szłapka E; Lozano-Ojalvo D; Willemsen LEM; Antunes CM; Molina E; Smit JJ; Wróblewska B; Wichers HJ; Knol EF; Ladics GS; Pieters RHH; Denery-Papini S; Vissers YM; Bavaro SL; Larré C; Verhoeckx KCM; Roggen EL
    Clin Transl Allergy; 2017; 7():13. PubMed ID: 28507730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Predictions for Molecular Initiating Events Using Three-Dimensional Quantitative Structure-Activity Relationships.
    Allen TEH; Goodman JM; Gutsell S; Russell PJ
    Chem Res Toxicol; 2020 Feb; 33(2):324-332. PubMed ID: 31517476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction Chemistry to Characterize the Molecular Initiating Event in Skin Sensitization: A Journey to Be Continued.
    Natsch A; Emter R
    Chem Res Toxicol; 2017 Jan; 30(1):315-331. PubMed ID: 28092944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Haptenation and Its Role in Allergy.
    Aleksic M; Meng X
    Chem Res Toxicol; 2024 Jun; 37(6):850-872. PubMed ID: 38834188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular target sequence similarity as a basis for species extrapolation to assess the ecological risk of chemicals with known modes of action.
    Lalone CA; Villeneuve DL; Burgoon LD; Russom CL; Helgen HW; Berninger JP; Tietge JE; Severson MN; Cavallin JE; Ankley GT
    Aquat Toxicol; 2013 Nov; 144-145():141-54. PubMed ID: 24177217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoavailability of Organic Electrophiles: Impact of Hydrophobicity and Reactivity on Their Aquatic Excess Toxicity.
    Böhme A; Laqua A; Schüürmann G
    Chem Res Toxicol; 2016 Jun; 29(6):952-62. PubMed ID: 27096880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrate mechanistic evidence from new approach methodologies (NAMs) into a read-across assessment to characterise trends in shared mode of action.
    Escher SE; Aguayo-Orozco A; Benfenati E; Bitsch A; Braunbeck T; Brotzmann K; Bois F; van der Burg B; Castel J; Exner T; Gadaleta D; Gardner I; Goldmann D; Hatley O; Golbamaki N; Graepel R; Jennings P; Limonciel A; Long A; Maclennan R; Mombelli E; Norinder U; Jain S; Capinha LS; Taboureau OT; Tolosa L; Vrijenhoek NG; van Vugt-Lussenburg BMA; Walker P; van de Water B; Wehr M; White A; Zdrazil B; Fisher C
    Toxicol In Vitro; 2022 Mar; 79():105269. PubMed ID: 34757180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Adverse Outcome Pathway (AOP) for forestomach tumors induced by non-genotoxic initiating events.
    Proctor DM; Suh M; Chappell G; Borghoff SJ; Thompson CM; Wiench K; Finch L; Ellis-Hutchings R
    Regul Toxicol Pharmacol; 2018 Jul; 96():30-40. PubMed ID: 29684431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactions of electrophiles with nucleophilic thiolate sites: relevance to pathophysiological mechanisms and remediation.
    LoPachin RM; Gavin T
    Free Radic Res; 2016; 50(2):195-205. PubMed ID: 26559119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse outcome pathway-driven identification of rat liver tumorigens in short-term assays.
    Rooney J; Hill T; Qin C; Sistare FD; Corton JC
    Toxicol Appl Pharmacol; 2018 Oct; 356():99-113. PubMed ID: 30048669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing adverse outcome pathways on silver nanoparticle-induced reproductive toxicity via oxidative stress in the nematode Caenorhabditis elegans using a Bayesian network model.
    Jeong J; Song T; Chatterjee N; Choi I; Cha YK; Choi J
    Nanotoxicology; 2018 Dec; 12(10):1182-1197. PubMed ID: 30663905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse outcome pathways: opportunities, limitations and open questions.
    Leist M; Ghallab A; Graepel R; Marchan R; Hassan R; Bennekou SH; Limonciel A; Vinken M; Schildknecht S; Waldmann T; Danen E; van Ravenzwaay B; Kamp H; Gardner I; Godoy P; Bois FY; Braeuning A; Reif R; Oesch F; Drasdo D; Höhme S; Schwarz M; Hartung T; Braunbeck T; Beltman J; Vrieling H; Sanz F; Forsby A; Gadaleta D; Fisher C; Kelm J; Fluri D; Ecker G; Zdrazil B; Terron A; Jennings P; van der Burg B; Dooley S; Meijer AH; Willighagen E; Martens M; Evelo C; Mombelli E; Taboureau O; Mantovani A; Hardy B; Koch B; Escher S; van Thriel C; Cadenas C; Kroese D; van de Water B; Hengstler JG
    Arch Toxicol; 2017 Nov; 91(11):3477-3505. PubMed ID: 29051992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular Pathway and AOP Development Using Gene Network Analysis].
    Tanabe S; Hirose A; Whelan M; Yamada T
    Yakugaku Zasshi; 2020; 140(4):485-489. PubMed ID: 32238629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adverse outcome pathway concept: a pragmatic tool in toxicology.
    Vinken M
    Toxicology; 2013 Oct; 312():158-65. PubMed ID: 23978457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Fragment-Based in Silico Profiler for Michael Addition Thiol Reactivity.
    Ebbrell DJ; Madden JC; Cronin MT; Schultz TW; Enoch SJ
    Chem Res Toxicol; 2016 Jun; 29(6):1073-81. PubMed ID: 27100370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of new chemical entities with decreased potential for adverse drug reactions.
    Park KB; Dalton-Brown E; Hirst C; Williams DP
    Eur J Pharmacol; 2006 Nov; 549(1-3):1-8. PubMed ID: 16979156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.